HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

BKYI

BIO-key International, Inc.

Industrials — Security & Protection Services

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.

Buy 2.0 / 5 1 analysts
$2.29
$-0.51 (-18.21%)
Target: $20.00 (773.4%)

Price History

52-Week Range
Sign in to add BKYI to a watchlist or set price alerts.

Fundamentals

Market Cap$4.76M
P/E Ratio (TTM)-
Forward P/E19.95
EPS (TTM)$-10.05
Dividend Yield-
Profit Margin-102.32%
Revenue Growth33.50%
ROE-106.71%
Debt/Equity14.45
Recommendation Buy 2.0
Analyst Target$20.00
Analysts1
Next Earnings -
Indexes -

Technical Indicators

RSI (14)42.4
Beta0.43
SMA 20$4.73
SMA 40$4.48
52-Week High$19.70
52-Week Low$3.10
50-Day Avg$4.49
200-Day Avg$6.04
Avg Volume65.0K
Volume40.6K

Performance Analysis

BULLISH

BKYI shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($3.10), which could present a value opportunity.
~ RSI at 42.4 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 33.5% year-over-year.
- Operating at a loss with -102.3% margin.
+ Wall Street consensus is "Buy" from 1 analysts.
+ Average analyst target of $20.00 implies 773.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:17 UTC

Back to Screener Export Report